Most splenic hemangiomas are not dangerous. They are benign growths made up of blood-filled spaces inside the spleen, and in roughly 80% of cases they cause no symptoms at all, turning up only when a scan is done for something else entirely. But “benign” and “harmless” are not the same thing. A small number of these tumors grow large enough to rupture, and a few trigger rare but serious blood-clotting problems. The gap between “probably fine” and “needs surgery” depends on size, growth behavior, and a handful of patient-specific factors worth understanding.
How Splenic Hemangiomas Are Usually Found
Tumors of the spleen are uncommon in general, but when a benign one does appear, a hemangioma is the most likely culprit. It is the most common benign primary tumor of the spleen.1PubMed Central. Giant splenic hemangioma in a 10-year-old boy treated with a spleen saving surgery That said, “most common benign tumor” in an organ that rarely develops tumors still means most doctors go an entire career without seeing more than a few.
The typical discovery story is anticlimactic. You go in for an abdominal CT or ultrasound because of kidney stones, gallbladder trouble, or a car accident, and the radiologist spots a mass in the spleen you never knew was there. In one review of 32 patients with splenic hemangiomas, about 80% were asymptomatic, with the lesion discovered incidentally during evaluation for unrelated conditions.2PubMed. Hemangioma of the spleen: presentation, diagnosis, and management The remaining patients had symptoms that could plausibly be linked to their hemangioma, and even then, a palpable mass or enlarged spleen was found in only a small fraction of cases. Sizes in that series ranged from 0.3 to 7 cm across.
When symptoms do occur, they tend to be vague: a dull ache or fullness in the upper left abdomen, sometimes radiating to the left shoulder. Larger hemangiomas can press on the stomach or colon and cause early satiety or discomfort after eating. None of these are specific enough to point straight to a splenic hemangioma, which is part of why imaging usually comes first and the diagnosis follows.
The Real Risks
The worry with a splenic hemangioma is not that it will turn cancerous. These tumors do not undergo malignant transformation. The worry is mechanical: a large, blood-filled mass in an organ with a rich blood supply can, in rare circumstances, rupture. If it does, the bleeding can be sudden and life-threatening. Case reports describe patients going into hemorrhagic shock after spontaneous rupture, presenting with abdominal pain, low blood pressure, and difficulty breathing.3International Surgery Journal. Spontaneous rupture of spleenic hemangioma: a case report Rupture has also been documented after unrelated surgical procedures. One report described a patient whose splenic hemangiomatosis ruptured following an open heart valve replacement.4PubMed Central. A Rare Case of Diffuse Hemangiomatosis of the Spleen with Splenic Rupture following Aortic Valve Replacement
Spontaneous rupture is rare, but its severity is the reason treatment is recommended for large splenic hemangiomas rather than indefinite watchful waiting. In a case involving an 11-year-old girl whose hemangioma measured roughly 6 cm with numerous smaller nodules throughout the spleen, the clinical team proceeded with treatment specifically because of the rupture risk.5PubMed Central. Splenic embolization for a giant splenic hemangioma in a child: a case report Even though these growths typically enlarge slowly, “slow” and “safe” are different calculations when the potential consequence is massive internal bleeding.
Kasabach-Merritt Syndrome
A second, rarer complication goes by the name Kasabach-Merritt syndrome. This occurs when a large cavernous hemangioma traps and destroys platelets within its tangled blood vessels, leading to anemia, dangerously low platelet counts, and problems with blood clotting.6PubMed Central. Kasabach-Merritt Syndrome Associated With a Large Cavernous Splenic Hemangioma Treated With Splenectomy The syndrome is uncommon even among people who already have an uncommon tumor, but it can be fatal if not recognized and treated quickly.7Journal of Pediatric Hematology/Oncology. A Rare Presentation of Isolated Congenital Splenic Hemangioma With Kasabach-Merritt Syndrome
Kasabach-Merritt syndrome has been documented in congenital cases as well, meaning a baby can be born with a splenic hemangioma that immediately causes clotting problems. In practice, when physicians find a large or rapidly growing splenic hemangioma paired with falling platelet counts and signs of consumptive coagulopathy, they treat urgently rather than monitoring.
Why the Diagnosis Can Be Tricky
One of the more stressful parts of having a splenic hemangioma is that imaging alone does not always give a definitive answer. These tumors come in two main subtypes, capillary and cavernous, and they look quite different on scans. Capillary hemangiomas tend to appear as bright, well-defined solid masses on ultrasound because their tightly packed small blood vessels reflect sound waves effectively. Cavernous hemangiomas, with their larger blood-filled spaces, often look darker and can contain a mix of cystic and solid features that mimic other lesions.8Insights into Imaging. Splenic cavernous and capillary hemangiomas – Imaging key findings and differential diagnosis
On MRI, most splenic hemangiomas appear bright on certain sequences and show a characteristic pattern of contrast enhancement that fills inward from the edges over time. One study of 22 hemangiomas imaged with MRI found that the vast majority showed this progressive filling pattern, which helps distinguish them from other splenic masses.9PubMed. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions Contrast-enhanced ultrasound offers another layer of information. In one series, about 78% of splenic hemangiomas had a uniform appearance on baseline ultrasound and roughly 82% showed no signal on color Doppler, meaning little to no detectable blood flow within the mass.10PubMed. Splenic hemangiomas: contrast-enhanced sonographic findings
The problem is that some hemangiomas do not follow these textbook patterns. Their imaging appearance can overlap with malignant splenic tumors like angiosarcoma or lymphoma, and in those cases differentiation from cancer on imaging alone may not be possible.11PubMed. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation The spleen can also harbor hamartomas, cysts, and metastases from cancers elsewhere in the body, all of which enter the list of possibilities when a radiologist sees a splenic mass.12PubMed. Solitary splenic lesions When imaging is ambiguous, a tissue biopsy becomes the definitive way to confirm the diagnosis and rule out malignancy.13Pediatric Health, Medicine and Therapeutics. Isolated Diffuse Splenic Hemangiomatosis Arising in an Adolescent: A Rare Case Report and Literature Review
This diagnostic uncertainty is, in itself, a source of anxiety for patients. Hearing “we see a mass in your spleen and we’re not sure what it is” can feel alarming even when the odds favor a benign explanation. In many cases, follow-up imaging over several months is enough to settle the question: a hemangioma that stays stable in size and shape is behaving exactly as expected, while rapid growth or changing features would prompt more aggressive investigation.
When Treatment Is Needed
Small, asymptomatic splenic hemangiomas generally do not require treatment. The standard approach is periodic imaging, often an ultrasound or MRI every six to twelve months initially, with intervals stretched out once the lesion proves stable. Many people live their entire lives with a splenic hemangioma and never need any intervention.
Treatment enters the conversation when a hemangioma is large (definitions vary, but masses above 4 to 5 cm often warrant closer attention), growing, causing symptoms, or creating diagnostic uncertainty that cannot be resolved by imaging alone. The available options fall into three broad categories: surgical removal, embolization, and, in some cases, a spleen-preserving partial resection.
Splenectomy and Partial Splenectomy
Total splenectomy, removing the entire spleen, has historically been the default surgical treatment. It is definitive: the hemangioma is gone, the tissue goes to pathology for a final diagnosis, and there is no chance of recurrence. But living without a spleen carries lifelong consequences, including heightened susceptibility to certain bacterial infections and a need for vaccinations and, in some cases, prophylactic antibiotics.
Partial splenectomy, removing only the portion of the spleen containing the hemangioma, has gained favor as an alternative when the tumor’s location allows it. A comparative study found that partial splenectomy reduced the incidence of post-operative platelet spikes, shortened hospital stays, and led to fewer cases of splenic vein blood clots compared with total splenectomy over an average follow-up of nearly three years.14PubMed. Partial Splenectomy is Superior to Total Splenectomy for Selected Patients with Hemangiomas or Cysts A pediatric case series echoed the platelet finding, with total splenectomy patients showing significantly higher platelet levels seven days after surgery than those who had a partial procedure.15PubMed Central. Surgical treatment of benign splenic lesions in pediatric patients: a case series of 30 cases from a single center The catch is that not every hemangioma is located in a spot that allows partial removal; tumors involving the splenic hilum, where the main blood vessels enter, are more likely to require total splenectomy.
One case report described a 10-year-old boy with a giant splenic hemangioma who was treated with a spleen-saving surgery, underscoring the growing preference for preserving as much functional splenic tissue as possible, especially in children whose immune systems benefit most from a working spleen.1PubMed Central. Giant splenic hemangioma in a 10-year-old boy treated with a spleen saving surgery
Embolization
Embolization is a minimally invasive alternative in which an interventional radiologist threads a catheter into the arteries feeding the hemangioma and blocks them. Cutting off the blood supply causes the tumor to shrink through localized tissue death while sparing the rest of the spleen. This approach has been described as a safer, less invasive option than splenectomy with a lower risk of bleeding.16PubMed Central. Organ-preserving embolization of a giant splenic hemangioma in an adult
The trade-off is that embolization can cause what is known as postembolization syndrome: abdominal pain and low-grade fever lasting days to weeks as the body reabsorbs the infarcted tissue. In the case of the 11-year-old girl treated with complete splenic artery embolization, the complications were a temporary spike in platelet count and postembolization syndrome with pain and intermittent fever, but no serious bleeding or other major problems.5PubMed Central. Splenic embolization for a giant splenic hemangioma in a child: a case report Embolization is particularly appealing when the goal is to avoid surgery altogether or to shrink a tumor enough to make a subsequent partial splenectomy easier.
Splenic Hemangiomas During Pregnancy
Pregnancy introduces a unique set of concerns. Estrogen, which surges throughout pregnancy, affects hemangiomas because these tumors express estrogen receptors. The hormonal changes, combined with the increased blood volume and altered blood vessel wall integrity that come with carrying a pregnancy, are thought to raise the risk of hemangioma growth and spontaneous rupture.17Journal of Vascular and Interventional Radiology. Embolization of a Splenic Hemangioma in Pregnancy This risk appears to be higher in women who have been pregnant before.
For a known large splenic hemangioma discovered during pregnancy, the decision-making becomes a careful balancing act. In one reported case of a giant splenic hemangioma found during advanced pregnancy, a multidisciplinary team opted for open splenectomy rather than continued observation. The concern was that the growing uterus could compress the enlarged spleen and trigger rupture, potentially killing both mother and baby.18International Journal of Surgery Case Reports. Giant splenic hemangioma during pregnancy: a case report These cases are extremely rare, but they highlight why women with known splenic hemangiomas should discuss the finding with their obstetric team before or early in pregnancy.
What Monitoring Looks Like in Practice
If you have been told you have a small, asymptomatic splenic hemangioma, the usual plan is straightforward: periodic imaging to confirm the mass is not growing, and a clear understanding of symptoms that should prompt an urgent visit. Sudden left-sided abdominal pain, light-headedness, and a rapid heartbeat after an injury to the torso (or even without one) are the red-flag symptoms that suggest possible rupture and warrant immediate medical attention.
Most people find that after one or two stable follow-up scans, their anxiety fades. The hemangioma is doing what the vast majority of hemangiomas do, which is sit quietly and cause no trouble. Your doctor may eventually recommend lengthening the interval between scans or stopping routine imaging altogether if the lesion remains unchanged over several years. There is no medication that shrinks splenic hemangiomas, and no dietary change or supplement that affects them.
The question of whether to avoid contact sports or certain physical activities comes up occasionally. There is no strong evidence base to guide this decision specifically for splenic hemangiomas, but common sense applies: an enlarged spleen from any cause is more vulnerable to traumatic rupture than a normal-sized one. If your hemangioma is large enough to enlarge the spleen, your doctor may suggest avoiding high-impact activities. For small, incidental findings, activity restrictions are typically unnecessary.
Capillary Versus Cavernous Subtypes
Not all splenic hemangiomas carry the same risk profile, and the distinction between capillary and cavernous subtypes matters clinically beyond just how they look on imaging. Capillary hemangiomas are composed of densely packed, small blood vessels. They tend to be smaller, more uniform in appearance, and generally lower risk. Cavernous hemangiomas, by contrast, contain large, dilated blood-filled cavities. They are the ones more commonly associated with growth to a large size, with the complications discussed earlier, including Kasabach-Merritt syndrome and rupture. The cavernous subtype also tends to produce more complex imaging appearances, which is part of why it is more often confused with malignancy on scans.8Insights into Imaging. Splenic cavernous and capillary hemangiomas – Imaging key findings and differential diagnosis
If your pathology report or imaging impression specifies the subtype, it is worth asking your doctor whether the distinction changes your monitoring plan. A small capillary hemangioma found incidentally in a healthy adult is about as low-risk a finding as you can get. A large cavernous hemangioma in the same patient calls for closer follow-up and a lower threshold for intervention.
Diffuse Hemangiomatosis
An unusual variant worth knowing about is diffuse splenic hemangiomatosis, where instead of a single well-defined mass, hemangiomas are scattered throughout the entire spleen. This pattern is extremely rare and tends to involve the cavernous subtype. It creates a more complicated clinical picture because there is no single lesion to remove or embolize; the entire organ is affected. Management usually requires total splenectomy, and the condition can involve other organs as well, particularly the liver.4PubMed Central. A Rare Case of Diffuse Hemangiomatosis of the Spleen with Splenic Rupture following Aortic Valve Replacement Diffuse hemangiomatosis is far less forgiving than a solitary hemangioma: the risk of rupture is higher, Kasabach-Merritt syndrome is more likely, and the diagnostic confusion with malignant vascular tumors is greater. If you have been given this specific diagnosis rather than a solitary splenic hemangioma, the conversation with your medical team will be meaningfully different.